Skip to main content
Fig. 6 | Journal of Translational Medicine

Fig. 6

From: Leveraging a cuproptosis-based signature to predict the prognosis and drug sensitivity of cutaneous melanoma

Fig. 6

Validate the ability of CRSS to predict the effect of immunotherapy in the immunotherapy cohort of other tumors. KM analysis was used to compare the difference of immunotherapy effect between high and low CRRS groups in Braun_2020 (A), GBM-PRJNA482620 (D), and nonsqNSCLC-GSE93157 (F) dataset. Comparison of CRRS of other tumor patients in different remission states after immunotherapy in Braun_2020 (B) and nonsqNSCLC-GSE93157 (H) dataset. Comparison of CRRS of other tumor patients in different response states after immunotherapy in Braun_2020 (C), GBM-PRJNA482620 (E), and nonsqNSCLC-GSE93157 (G) dataset. *: P < 0.05; **: P < 0.01; ***: P < 0.001; ****: P < 0.0001

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us